Fildena 100 need to be made aware of the potential dangers of counterfeit versions of this medication. They should be educated on how to identify genuine products and the health risks associated with using fake medications. Healthcare Providers: Doctors, pharmacists, and other healthcare professionals who may prescribe or dispense Fildena 100 should be informed about the counterfeit drug issue. They can then educate their patients and watch out for suspicious products. Regulatory Authorities: National and international regulatory bodies, such as the FDA, EMA, or WHO, should be notified about the circulation of counterfeit Fildena 100 in order to investigate the issue and take appropriate enforcement actions. Pharmaceutical Companies: The manufacturer of the legitimate Fildena 100 product, Fortune Healthcare, should be made aware of the counterfeit problem so they can work to protect their supply chain and notify distribution partners. Law Enforcement: Police and customs authorities should be informed, as they play a crucial role in identifying, seizing, and preventing the distribution of counterfeit drugs. Raising awareness among these key stakeholders is important to address the risks posed by counterfeit Fildena 100 and protect public health. Effective communication and coordination between these groups is essential. GPT-4&Web Access Add Skills